ImmuCell Corporation (ICCC)

ImmuCell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	48	46	39	47	62	43
Market Cap Growth	52.83%	16.33%	-16.51%	-23.70%	44.31%	15.59%
Enterprise Value	57	58	54	51	62	48
Last Close Price	5.21	5.15	5.09	6.10	8.00	5.95
PE Ratio	20.18	-	-	-	-	-
PS Ratio	1.69	1.73	2.26	2.55	3.22	2.80
PB Ratio	1.58	1.67	1.58	1.56	1.90	1.52
P/TBV Ratio	1.59	1.68	1.59	1.56	1.91	1.53
P/FCF Ratio	65.88	-	-	-	-	-
P/OCF Ratio	23.69	128.23	-	-	64.91	32.62
EV/Sales Ratio	2.05	2.17	3.10	2.76	3.22	3.13
EV/EBITDA Ratio	10.46	39.63	-	65.78	22.78	49.62
EV/EBIT Ratio	20.78	-	-	-	240.62	-
EV/FCF Ratio	79.47	-	-	-	-	-
Debt / Equity Ratio	0.46	0.55	0.67	0.41	0.32	0.38
Debt / EBITDA Ratio	2.29	7.75	-	12.96	3.57	9.69
Debt / FCF Ratio	19.02	-	-	-	-	-
Asset Turnover	0.62	0.60	0.39	0.42	0.45	0.39
Inventory Turnover	1.85	2.43	1.89	2.26	4.09	3.68
Quick Ratio	1.63	1.72	0.76	2.47	5.09	4.44
Current Ratio	4.21	3.41	2.73	4.56	6.42	5.50
Return on Equity (ROE)	8.27%	-8.21%	-20.86%	-7.92%	-0.26%	-3.57%
Return on Assets (ROA)	3.79%	-1.73%	-7.36%	-2.39%	0.38%	-2.18%
Return on Capital (ROIC)	4.01%	-1.83%	-7.72%	-2.49%	0.39%	-2.26%
Return on Capital Employed (ROCE)	6.60%	-3.00%	-13.20%	-4.10%	0.60%	-3.60%
Earnings Yield	4.93%	-4.70%	-14.64%	-5.28%	-0.13%	-2.38%
FCF Yield	1.52%	-0.24%	-16.64%	-11.68%	-2.67%	-6.42%
Buyback Yield / Dilution	-14.38%	-5.42%	-0.03%	-2.01%	-5.25%	-5.78%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q